🇺🇸 Iodixanol 320 in United States
28 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 28
Most-reported reactions
- Contrast Media Reaction — 5 reports (17.86%)
- Renal Failure Acute — 5 reports (17.86%)
- Blood Creatinine Increased — 4 reports (14.29%)
- Nephropathy Toxic — 3 reports (10.71%)
- Pyrexia — 3 reports (10.71%)
- Dyspnoea — 2 reports (7.14%)
- Hypotension — 2 reports (7.14%)
- Vomiting — 2 reports (7.14%)
- Acute Myocardial Infarction — 1 report (3.57%)
- Acute Prerenal Failure — 1 report (3.57%)
Other Diagnostic Imaging approved in United States
Frequently asked questions
Is Iodixanol 320 approved in United States?
Iodixanol 320 does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Iodixanol 320 in United States?
Bracco Diagnostics, Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.